Lifeward receives European approval for ReWalk 7 exoskeleton
Tweet Send to a Friend
Lifeward Ltd. (NASDAQ: LFWD) announced it received CE mark approval for its ReWalk 7 Personal Exoskeleton, enabling commercial sales across ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


